Venture Valuation Inc.

Booth 1743
Zürich, Zurich, Switzerland
Venture Valuation specializes in independent assessments and valuations of companies in high-growth markets, such as biotechnology, life sciences and medical technology. Further more, the company runs the global business development Database Biotechgate ( as a subscription service. There are currently over 60,000 company profiles available and information is provided in collaboration with our partners such as AusBiotech, BIO Deutschland, California Life Sciences Association, BIO Maryland, Swiss Biotech Association, Seoul BioHub, Medicon Valley, HollandBIO and many more. Venture Valuation has office in Switzerland (HQ), Ireland, UK, Singapore, India, USA and Canada.

Company Valuation:
The Company Valuation Reports include a thorough assessment of the company by experienced professionals with expertise in the relevant fields as well as the following elements: • summary of key risk parameters and strengths of the company • outline of the crucial factors and value drivers for growth and further strategic development • assessment of the management, market, science, technology and products • analysis of the company’s business model and the company’s competitive environment • detailed calculation of the company’s financial value, using appropriate valuation methods

Product Valuation:
Venture Valuation offers detailed Product Valuation Reports of pre-clinical and clinical products in development that can serve as a basis for negotiations or to structure different deal scenarios. The Product Valuation includes: • detailed analysis of development costs, time lines, patient population, competing products, pricing and product life cycle • industry gold standard rNPV valuation methodology based on indication-specific attrition rates and the development stage • scenario and sensitivity analyses • analysis of the current value, and forecasts of the future value following the successful completion of key development milestones As an “add on” module and based on Venture Valuation’s deal database within Biotechgate, benchmarking deals can also be included to provide the client with a differentiated negotiation basis and comparable information.

Licensing Candidate Search:
Based on unique valuation and industry expertise, and leveraging access to the proprietary client and products database, Venture Valuation offers individual, tailor-made solutions to customers. The Licensing Candidate Search includes licensing partner identification and an evaluation of potential products for licensing.

Biotechgate Business Development Database:
Venture Valuation has developed and maintains Biotechgate ( Biotechgate is a global business development database established in 2004 based on the needs of investors and company managers to access accurate and up-to-date industry intelligence. The database contains over 65’000 company profiles, 90'000 assets and more than 750'000 clinical trials. For Business Development managers, the database provides benchmarking licensing opportunities as well as detailed financial information covering more than 25’000 licensing deals involving therapeutic products and over 25’000 financing rounds. The database consists of:
- Business Development Database including licensing opportunities, assets, license agreements and contact details
- Life Sciences Investors Database including dedicated mandate and contact details